Your browser doesn't support javascript.
loading
Efficacy and safety of trifluridine/tipiracil in older and younger patients with metastatic gastric or gastroesophageal junction cancer: subgroup analysis of a randomized phase 3 study (TAGS).
Shitara, Kohei; Doi, Toshihiko; Hosaka, Hisashi; Thuss-Patience, Peter; Santoro, Armando; Longo, Federico; Ozyilkan, Ozgur; Cicin, Irfan; Park, David; Zaanan, Aziz; Pericay, Carles; Özgüroglu, Mustafa; Alsina, Maria; Makris, Lukas; Benhadji, Karim A; Ilson, David H.
Afiliação
  • Shitara K; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa-shi, Chiba, 277-8577, Japan. kshitara@east.ncc.go.jp.
  • Doi T; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa-shi, Chiba, 277-8577, Japan.
  • Hosaka H; Department of Gastroenterology, Gunma Prefectural Cancer Center, Ota, Gunma, Japan.
  • Thuss-Patience P; Medizinische Klinik m.S. Hämatologie, Onkologie und Tumorimmunologie, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Santoro A; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20072, Milan, Italy.
  • Longo F; IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Via Manzoni 56, Rozzano, 20089, Milan, Italy.
  • Ozyilkan O; Medical Oncology, Hospital Universitario Ramon y Cajal, IRYCIS, CIBERONC, Madrid, Spain.
  • Cicin I; Medical Oncology, Baskent University Adana Practice and Research Centre Kisla, Adana, Turkey.
  • Park D; Department of Internal Medicine, Division of Medical Oncology, School of Medicine, Trakya University, Edirne, Turkey.
  • Zaanan A; Hematology and Oncology, St. Jude Crosson Cancer Institute/St. Joseph Heritage Healthcare, Fullerton, CA, USA.
  • Pericay C; Department of Gastrointestinal Oncology, European Georges Pompidou Hospital, AP-HP Centre, University of Paris, Paris, France.
  • Özgüroglu M; Medical Oncology, Corporación Sanitaria Parc Tauli, Barcelona, Spain.
  • Alsina M; Department of Internal Medicine, Division of Medical Oncology, Clinical Trial Unit, Cerrahpasa School of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Makris L; Medical Oncology Department, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Benhadji KA; Stathmi, Inc., New Hope, PA, USA.
  • Ilson DH; Clinical Development, Taiho Oncology, Inc., Princeton, NJ, USA.
Gastric Cancer ; 25(3): 586-597, 2022 05.
Article em En | MEDLINE | ID: mdl-34997449

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Neoplasias Colorretais / Demência Frontotemporal Tipo de estudo: Clinical_trials Limite: Aged / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Neoplasias Colorretais / Demência Frontotemporal Tipo de estudo: Clinical_trials Limite: Aged / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article